Patents for C12P 21 - Preparation of peptides or proteins (112,499)
05/2004
05/19/2004EP1151143A4 Selection of proteins using rna-protein fusions
05/19/2004EP1137935B1 Detection of preharvest sprouting in cereal grains
05/19/2004EP1037927B1 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
05/19/2004EP1007551B1 Vaccine against hpv
05/19/2004EP0870026B1 Ob protein derivatives having prolonged half-life
05/19/2004EP0832253B1 Nucleic acid respiratory syncytial virus vaccines
05/19/2004EP0787190B1 Hepatitis e virus antigens and uses therefor
05/19/2004EP0711173B1 Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof
05/19/2004EP0682703B1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS
05/19/2004CN1498271A Potassium channel interactors protein and uses therefor
05/19/2004CN1496992A Recombination soluble tissue factor and preparation method and opplication thereof
05/19/2004CN1150327C Producing erythrocyte irritable factor/granulocyte colony irritable factor fusion protein by genetic engineering method
05/19/2004CN1150324C Novel human lysozyme gene, its encoding polypeptide and the method preparing for them
05/19/2004CN1150318C Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies
05/19/2004CN1150317C Gene associated with esophagus cancer
05/19/2004CN1150313C Method for the production of polypeptides
05/19/2004CN1150207C Gclq receptor, HIV-1 ph120 region binding thereto, and related peptides and targeting antibodies
05/19/2004CN1150030C 重组人甲胎蛋白及其用途 And its use of recombinant human alpha-fetoprotein
05/18/2004US6737522 Chicken interleukin-15 and uses thereof
05/18/2004US6737413 SOX-9 gene and protein and use in the regeneration of bone or cartilage
05/18/2004US6737403 Culturing microorganism streptomyces viridochromogenes, ssp. komabensis (atcc 29814) in culture medium, isolating laspartomycin, cleaving lipophilic fragment from laspartomycin, thereby yielding laspartomycin core peptide
05/18/2004US6737273 Bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
05/18/2004US6737267 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof
05/18/2004US6737251 Nucleotide and deduced amino acid sequences of tumor gene Int6
05/18/2004US6737250 Plasmid for use in the generation of genetically engineered amino acid sequences
05/18/2004US6737248 Apparatus for use in the detection of bacterial infections
05/18/2004US6737243 Determination of the hydrophobic pulmonary surfactant protein SP-C
05/18/2004US6737233 Method for preparing HCV E2 binding protein
05/18/2004US6737232 IAPs associated cell cycle proteins, compositions and methods of use
05/18/2004US6737074 Cells in a culture medium bind to fibrin microbeads which are biologically active and comprise very crosslinked fibrin(ogen); transplanting; engineering tissue by applying to a prosthesis; separating cells; wound healing agents
05/18/2004US6737063 Immunological polypeptides; vaccine against gramnegative bacteria
05/18/2004US6737059 Methods of inhibiting inflammatory processes and alleviating symptoms associated with multiple sclerosis
05/18/2004CA2343719C New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof
05/18/2004CA2343715C New human growth differentiation factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof
05/13/2004WO2004039984A1 Recombinant protein expression
05/13/2004WO2004039963A2 Antibodies specific for phosphorylated insulin receptor substrate-1/2 (ser 1101/ser1149) and uses thereof
05/13/2004WO2004039951A2 Il-1 receptor based antagonists and methods of making and using
05/13/2004WO2004039844A1 Prostate cancer tumor marker
05/13/2004WO2004039234A2 Humanized antibodies against the venezuelan equine encephalitis virus
05/13/2004WO2004027072A3 Method for making recombinant proteins
05/13/2004WO2004020609A9 Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection
05/13/2004WO2004019990A9 Therapeutic system targeting pathogen proteases and uses thereof
05/13/2004WO2004009793A3 Synthesis of glycoproteins using bacterial gycosyltransferases
05/13/2004WO2004000415A3 Tissue reconstruction and regeneration
05/13/2004WO2003093453A3 Bacillus licheniformis mutant host cell
05/13/2004WO2003087838A8 Compositions, methods and kits for immunochemical determination of mannan-binding lectin (mbl)
05/13/2004WO2003079750A3 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
05/13/2004WO2003070190A3 Surrogate antibodies and methods of preparation and use thereof
05/13/2004WO2003068163A3 Optimization of gene sequences of chimeric virus-like particles for expression in insect cells
05/13/2004WO2003057014A3 Biomarkers for detecting ovarian cancer
05/13/2004WO2003053921A9 Mutant proteinase inhibitors and uses thereof
05/13/2004WO2003052050A3 P450 enzymes, nucleic acids encoding them and methods of making and using them
05/13/2004WO2003034903B1 Psma antibodies and protein multimers
05/13/2004WO2002048377A8 Polynucleotide encoding chimeric protein and related vectors, cells, and methods of expression thereof
05/13/2004WO2002016440A9 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections
05/13/2004WO1992004464A3 Monoclonal antibodies against tenascin
05/13/2004US20040092719 Using hydrophobic interaction chromatography to separate and isolated heavy chain modified immunoglobulins
05/13/2004US20040092714 Comprises osteoclast associated receptors (OSCAR) for the identifying modulators for treatment of bone disorders
05/13/2004US20040092711 Hybrid expression of neisserial proteins
05/13/2004US20040092545 Sulfonamido ether substituted imidazoquinolines
05/13/2004US20040092007 Allelic growth differentiation factor-9b (GDF-9B) for treatment annd prevention of sex disorders; in vitro fertilization; artificial insemination; veterinary medicine
05/13/2004US20040091974 Anti-hla-dr antibody
05/13/2004US20040091973 Process for selecting anti-angiognesis antibody fragments, anti-angiogenesis antibody fragments thus obtained and their use
05/13/2004US20040091972 Membrane protein for diagnosis, prevention and treatment cell proliferative disorders
05/13/2004US20040091959 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; diagnosis cancer
05/13/2004US20040091958 Expression vector coding glyceraldehyde-3-phosphate dehydrogenase for transformation of phaffa and biosyntnhesis of astaxanthin
05/13/2004US20040091957 Preparing deglycosylated immunoglobulin using proteolytic cleavage for use in medical diagnostics, chemical assays, drug screening and proteomics
05/13/2004US20040091955 Process and compositions for peptide, protein and peptidomimetic synthesis
05/13/2004US20040091904 Methods for identifying compounds that bind to a target
05/13/2004US20040091895 Human sprouty-4 polypeptide
05/13/2004US20040091894 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof
05/13/2004US20040091883 Method for analysing and displaying ORF as well as UTR in cDNA sequences and its application to protein synthesis
05/13/2004US20040091878 Zinc finger domain recognition code and uses thereof
05/13/2004US20040091854 Polypeptides derived from rna polymerases and use thereof
05/13/2004US20040091578 Treating a protein containing disulfide bonds withthioredoxin, nicotinamide adenine dinucleotide phosphate- thioredoxin reductase and NADPH or dithiothreitol reacting the protein with physiological disulfide; administering
05/13/2004US20040091497 Use as a biological target for the treatment and diagnosis of schizophrenia and bipolar disorder for example; drug screening; transgenic non-human animals for use as animal models
05/13/2004US20040091496 Vaccine
05/13/2004US20040091488 Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereof
05/13/2004US20040091485 Humanised antibodies to the epidermal growth factor receptor
05/13/2004US20040091484 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
05/13/2004US20040091478 Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding
05/13/2004US20040091476 Enhance or suppress T-cell activation and proliferation
05/13/2004US20040091468 Novel transcriptional mediators of blood vessel development and endothelial differentiation
05/13/2004CA2485342A1 Humanized antibodies against the venezuelan equine encephalitis virus
05/12/2004EP1418235A2 Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies
05/12/2004EP1418234A1 Human monoclonal antibodies against oxidized ldl receptor and medicinal use thereof
05/12/2004EP1418183A1 Cystic fibrosis gene
05/12/2004EP1418179A2 Compositions and methods for detecting and modulating rna activity and gene expression
05/12/2004EP1417338A1 Genes and snps associated with eating disorders
05/12/2004EP1417315A2 Plant ion channels and methods
05/12/2004EP1417308A1 Human protooncogene kg-20 and protein encoded therein
05/12/2004EP1417301A2 Carbohydrates and polyols for dissolving protein crystals
05/12/2004EP1417299A1 New biopesticide using gene from erwinia pyrifoliaewt 3, novel pathogen that affects asian pear trees
05/12/2004EP1417237A1 Process for preparation of polypeptides of interest from fusion peolypeptides
05/12/2004EP1417232A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
05/12/2004EP1417231A2 Modified human thymic stromal lymphopoietin
05/12/2004EP1417229A2 Methods and compounds for the targeting of protein to exosomes
05/12/2004EP1417224A2 Secreted proteins
05/12/2004EP1417221A2 Mimotope of neisseria meningitidis lipooligosaccharide and vaccines containing the same
05/12/2004EP1417217A2 Inhibition of behab cleavage and primary central nervous system (cns) tumors